Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Akiba

Showing results (241-250 of 276) with videos related to

Pageof 28
Sort By:
Anticancer Research|October 3, 2018
PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung CancerShinkichi Takamori, Kazuki Takada, Gouji Toyokawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2026
Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case ReportEtsuko Moriyama, Hironori Koga, Takashi Niizeki, et al.
Anticancer Research|July 27, 2023
Significance of Desmoplastic Histopathological Growth Pattern for Colorectal Liver Metastases Treated With Preoperative ChemotherapyHiroaki Hirakawa, Hisamune Sakai, Hiroki Kanno, et al.
Anticancer Research|August 2, 2019
Clinicopathological Study of Resections of Intraductal Papillary Neoplasm of the Bile DuctToshihiro Sato, Toru Hisaka, Hisamune Sakai, et al.
Molecular Cancer|May 6, 2016
ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cellsHiroto Fukushima, Makiko Yasumoto, Sachiko Ogasawara, et al.
Pathology, Research and Practice|September 10, 2022
Prognostic impact of vessels encapsulating tumor clusters and macrotrabecular patterns in hepatocellular carcinomaJun Akiba, Masamichi Nakayama, Eiji Sadashima, et al.
Anticancer Research|March 31, 2021
The Expression of PEDF and its Putative Receptors in Hepatocellular Carcinoma and Background Liver TissueJun Akiba, Takafumi Yoshida, Eiji Sadashima, et al.
Cancer Medicine|November 29, 2016
Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancerMakiko Yasumoto, Etsuko Sakamoto, Sachiko Ogasawara, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|May 3, 2018
The expression of programed death ligand-1 could be related with unfavorable prognosis in salivary duct carcinomaFumihiko Sato, Jun Akiba, Akihiko Kawahara, et al.
Molecular and Clinical Oncology|March 26, 2021
Investigation of clinicopathological characters and gene expression features in colorectal signet-ring cell carcinoma utilizing CMS classificationKensuke Tajiri, Tomoya Sudo, Kazuo Ishi, et al.
Pageof 28

Showing results (241-250 of 276) with videos related to

Sort By:
Pageof 28
Anticancer Research|October 3, 2018
PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung CancerShinkichi Takamori, Kazuki Takada, Gouji Toyokawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2026
Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case ReportEtsuko Moriyama, Hironori Koga, Takashi Niizeki, et al.
Anticancer Research|July 27, 2023
Significance of Desmoplastic Histopathological Growth Pattern for Colorectal Liver Metastases Treated With Preoperative ChemotherapyHiroaki Hirakawa, Hisamune Sakai, Hiroki Kanno, et al.
Anticancer Research|August 2, 2019
Clinicopathological Study of Resections of Intraductal Papillary Neoplasm of the Bile DuctToshihiro Sato, Toru Hisaka, Hisamune Sakai, et al.
Molecular Cancer|May 6, 2016
ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cellsHiroto Fukushima, Makiko Yasumoto, Sachiko Ogasawara, et al.
Pathology, Research and Practice|September 10, 2022
Prognostic impact of vessels encapsulating tumor clusters and macrotrabecular patterns in hepatocellular carcinomaJun Akiba, Masamichi Nakayama, Eiji Sadashima, et al.
Anticancer Research|March 31, 2021
The Expression of PEDF and its Putative Receptors in Hepatocellular Carcinoma and Background Liver TissueJun Akiba, Takafumi Yoshida, Eiji Sadashima, et al.
Cancer Medicine|November 29, 2016
Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancerMakiko Yasumoto, Etsuko Sakamoto, Sachiko Ogasawara, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|May 3, 2018
The expression of programed death ligand-1 could be related with unfavorable prognosis in salivary duct carcinomaFumihiko Sato, Jun Akiba, Akihiko Kawahara, et al.
Molecular and Clinical Oncology|March 26, 2021
Investigation of clinicopathological characters and gene expression features in colorectal signet-ring cell carcinoma utilizing CMS classificationKensuke Tajiri, Tomoya Sudo, Kazuo Ishi, et al.
Pageof 28